Browsing NTNU Open by Author "Evensen, Morten Egeberg"

Now showing items 1-2 of 2

    • Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH- mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden 

      Heggebø, Liv Cathrine; Borgen, Ida Maria Henriksen; Rylander, Hillevi; Kiserud, Cecilie E.; Nordenmark, Tonje Kristin Haug; Hellebust, Taran Annette Paulsen; Evensen, Morten Egeberg; Gustavsson, Magnus; Ramberg, Christina; Sprauten, Mette; Magelssen, Henriette; Blakstad, Hanne; Moorthy, Janani; Andersson, Karin; Raunert, Ingela; Henry, Thomas; Moe, Cecilie; Granlund, Carin; Goplen, Dorota; Brekke, Jorunn; Johannessen, Tor-Christian Aase; Solheim, Tora S; Marienhagen, Kirsten; Humberset, Øyvind; Bergström, Per; Agrup, Måns; Dahl, Ludvig; Gubanski, Michael; Gojon, Helene; Brahme, Carl-Johan; Rydén, Isabelle; Jakola, Asgeir Store; Vik-Mo, Einar O.; Lie, Hanne Cathrine; Asphaug, Lars; Hervani, Maziar; Kristensen, Ingrid; Rüegg, Corina Silvia; Olsen, Inge Christoffer; Ledal, Rolf J; Degsell, Eskil; Werlenius, Katja; Blomstrand, Malin; Brandal, Petter (Peer reviewed; Journal article, 2023)
      Abstract Introduction The use of proton therapy increases globally despite a lack of randomised controlled trials demonstrating its efficacy and safety. Proton therapy enables sparing of non-neoplastic tissue from ...

    • Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy 

      Stokkevåg, Camilla Hanquist; Indelicato, Daniel J.; Herfarth, Klaus; Magelssen, Henriette; Evensen, Morten Egeberg; Ugland, Maren; Nordberg, Terje; Nystad, Tove Anita; Hægeland, Camilla; Alsaker, Mirjam Delange; Ulven, Kjetil; Dale, Jon Espen; Engeseth, Grete May; Boer, Camilla G.; Toussaint, Laura; Kornerup, Josefine Frida Margareta Ståhl; Pettersen, Helge Egil Seime; Brydøy, Marianne; Brandal, Petter; Muren, Ludvig Paul (Peer reviewed; Journal article, 2019)
      Background: Children with brain tumors undergoing radiotherapy are at particular risk of radiation-induced morbidity and are therefore routinely considered for proton therapy (PT) to reduce the dose to healthy tissues. The ...